Centessa Pharmaceuticals (CNTA) EPS (Weighted Average and Diluted) (2022 - 2025)
Historic EPS (Weighted Average and Diluted) for Centessa Pharmaceuticals (CNTA) over the last 4 years, with Q3 2025 value amounting to -$0.41.
- Centessa Pharmaceuticals' EPS (Weighted Average and Diluted) fell 1081.08% to -$0.41 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.9, marking a year-over-year decrease of 2500.0%. This contributed to the annual value of -$2.06 for FY2024, which is 3117.77% down from last year.
- As of Q3 2025, Centessa Pharmaceuticals' EPS (Weighted Average and Diluted) stood at -$0.41, which was down 1081.08% from -$0.38 recorded in Q2 2025.
- Over the past 5 years, Centessa Pharmaceuticals' EPS (Weighted Average and Diluted) peaked at -$0.2 during Q1 2025, and registered a low of -$0.97 during Q4 2024.
- For the 4-year period, Centessa Pharmaceuticals' EPS (Weighted Average and Diluted) averaged around -$0.47, with its median value being -$0.4 (2023).
- Its EPS (Weighted Average and Diluted) has fluctuated over the past 5 years, first soared by 6231.88% in 2023, then tumbled by 16284.63% in 2024.
- Quarter analysis of 4 years shows Centessa Pharmaceuticals' EPS (Weighted Average and Diluted) stood at -$0.45 in 2022, then rose by 17.78% to -$0.37 in 2023, then crashed by 162.85% to -$0.97 in 2024, then skyrocketed by 57.84% to -$0.41 in 2025.
- Its EPS (Weighted Average and Diluted) stands at -$0.41 for Q3 2025, versus -$0.38 for Q2 2025 and -$0.2 for Q1 2025.